3 results
To determine if aspiration thrombectomy can reduce the rate of cardiovascular death, recurrent myocardial infarction, cardiogenic shock, or new or worsening NYHA Class IV heart failure in patients with STEMI undergoing primary PCI.
To demonstrate that treatment with drotrecogin alfa (activated) 24 mcg/kg/h administered as an intravenous infusion for 96 hours reduces 28 day all-cause mortality in adult patients with septic shock compared with placebo.
Determining a response characteristic of the vestibulocochlear nerve in healthy subjects (e.g. subjects without hearing loss or tinnitus), for the benefit of assessing possible aberrant characteristics in subjects with tinnitus, which data could be…